Stay updated on Orlistat Adjuvant in Obesity: Clinical Trial
Sign up to get notified when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.

Latest updates to the Orlistat Adjuvant in Obesity: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.SummaryDifference7%
- Check23 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.8%
- Check37 days agoChange DetectedPrimarily a version bump from v3.0.1 to v3.0.2. The removal of the 'Back to Top' link is a minor UI tweak, with no substantive changes to core content, pricing, or time-slot information.SummaryDifference0.4%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.4%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in Brazil, as well as new topics related to drug safety and health conditions. Notably, the revision number has been updated to v3.0.0.SummaryDifference6%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.2%
Stay in the know with updates to Orlistat Adjuvant in Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.